Ö§Á´°±»ùËáת°±Ã¸(BCAT)»îÐԲⶨÊÔ¼ÁºÐ΢°å·¨/48Ñù
²â¶¨¹æ¸ñ£º48Ñù
ÓРЧ ÆÚ£º£¶¸öÔÂ
²â¶¨·½·¨£ºÎ¢°å·¨
±£´æÌõ¼þ£ºµÍαܹⱣ´æ
²úÆ·¼ò½é:
Ö§Á´°±»ùËáת°±Ã¸(BCAT, E.C.2.6.1.42) ÊôÓÚÒÔÁ×ËáßÁ¶ßÈ©×÷Ϊ¸¨Ã¸µÄ¢ôÀàת°±Ã¸¡£¸Ãø·Ö²¼Ê®·Ö¹ã·º£¬ÒѾ·¢Ïֹ㷺´æÔÚÓÚÔºËÉúÎïºÍ´ó¶àÊýÕæºËÉúÎïÖС£Ö§Á´°±»ùËáת°±Ã¸(BCAT)´ß»¯ÌØÒì L-ÐͰ±»ùËá°±»ù×ªÒÆµ½¦Á-ͪÎì¶þËᣬÐγÉÏàÓ¦µÄÖ§Á´¦Á-ͪËáºÍ¹È°±Ë᣻ÔÙÓÃÌØÒì×÷ÓÃÓڹȰ±ËáµÄø¸´ºÏÌå·Ö½â¹È°±ËᣬͬʱÓëÏÔÉ«¼Á·´Ó¦Éú³É»ÆÉ«ÎïÖÊ£¬¸ÃÎïÖÊÔÚ450nm´¦ÓÐ×î´óÎüÊշ壬½ø¶øµÃµ½Ö§Á´°±»ùËáת°±Ã¸(BCAT)µÄø»îÐÔ´óС¡£
¸Ãø´ß»¯·´Ó¦£ºL-leucine+2-oxoglutarate=4-methyl-2-oxopentanoate + L-glutamate¡£
ÊÔ¼ÁºÐ×é³ÉºÍÅäÖÆ:
|
ÊÔ¼ÁÃû³Æ |
¹æ¸ñ |
±£´æÒªÇó |
±¸×¢ |
|
ÌáȡҺ |
ÒºÌå 60mL¡Á1 Æ¿ |
4¡æ±£´æ |
|
|
ÊÔ¼ÁÒ» |
·Û¼Á mg¡Á1 Ö§ |
4¡æ±£´æ |
ÓÃǰ˦¼¸Ï»ò4¡æÀëÐÄʹÊÔ¼ÁÂäÈëÊԹܵײ¿£¬ÔÙ¼Ó2.2mLµÄÕôÁóË®³ä·ÖÈܽ⣬ÈÔ4¡æ±£´æ¡£ |
|
ÊÔ¼Á¶þ |
·Û¼Á mg¡Á1 Ö§ |
4¡æ±£´æ |
ÓÃǰ˦¼¸Ï»ò4¡æÀëÐÄʹÊÔ¼ÁÂäÈëÊԹܵײ¿£¬ÔÙ¼Ó1.2mLÕôÁóË®ÈܽⱸÓá£ÈÔ4¡æ±£´æ¡£ |
|
ÊÔ¼ÁÈý |
·Û¼Á mg¡Á1 Ö§ |
4¡æ±£´æ |
ÓÃǰ˦¼¸Ï»ò4¡æÀëÐÄʹÊÔ¼ÁÂäÈëÊԹܵײ¿£¬ÔÙ¼Ó1.1mLÕôÁóË®ÈܽⱸÓá£ÈÔ4¡æ±£´æ¡£ |
|
ÊÔ¼ÁËÄ |
ÒºÌå 20mL¡Á1 Æ¿ |
4¡æ±£´æ |
|
|
ÊÔ¼ÁÎå |
ÒºÌå 2mL¡Á1 Ö§ |
4¡æ±£´æ |
|
|
ÊÔ¼ÁÁù |
·Û¼Á mg¡Á1 Ö§ |
-20¡æ±£´æ |
ÓÃǰ˦¼¸Ï»ò4¡æÀëÐÄʹÊÔ¼ÁÂäÈëÊԹܵײ¿£¬ÔÙ¼Ó 1.1mL ÕôÁóË®ÈܽⱸÓá£ÈÔ-20¡æ±£´æ¡£ |
|
ÊÔ¼ÁÆß |
ÒºÌå 1mL¡Á1 Ö§ |
4¡æ±£´æ |
|
|
±ê׼Ʒ |
ÒºÌå mL¡Á1 Ö§ |
4¡æ±£´æ |
|
ËùÐèµÄÒÇÆ÷ºÍÓÃÆ·:
ø±êÒÇ¡¢96 ¿×°å¡¢Ì¨Ê½ÀëÐÄ»ú¡¢Ë®Ô¡¹ø¡¢¿Éµ÷Ê½ÒÆÒºÆ÷¡¢Ñв§¡¢±ùºÍÕôÁóË®¡£
Ö§Á´°±»ùËáת°±Ã¸(BCAT)ø»îÐÔ¼ì²â:
½¨ÒéÕýʽʵÑéǰѡȡ 2 ¸öÑù±¾×öÔ¤²â¶¨£¬Á˽ⱾÅúÑùÆ·Çé¿ö£¬ÊìϤʵÑéÁ÷³Ì£¬±ÜÃâʵÑéÑù±¾ºÍÊÔ¼ÁÀË·Ñ£¡
¹ºÎï³µ
°ïÖú
021-54845833/15800441009
